Learn More
Invitrogen™ Basiliximab Chimeric Recombinant Rabbit Monoclonal Antibody (Basiliximab)

Description
Specificity: Basiliximab recognises the human IL-2R and binds to the epitope (116)ERIYHFV(122) within the extracellular domain of the CD25 subunit-binding is abolished when 2 or more residues within the epitope are mutated. This epitope overlaps with the interaction site of CD25 and IL-2. CD25 is found in the high-affinity IL-2R (alpha-Beta-gamma-c)-T cells only express CD25 upon activation. IL-2 binding to IL-2R on T cells modulates proliferation and differentiation.
Specifications
Specifications
| Antigen | Basiliximab Chimeric |
| Applications | Flow Cytometry, Inhibition Assays, Immunohistochemistry, Western Blot, Immunocytochemistry |
| Classification | Recombinant Monoclonal |
| Clone | Basiliximab |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% ProClin 300 |
| Gene Alias | CHI621 |
| Host Species | Rabbit |
| Immunogen | Basiliximab was prepared by immunizing BALB/c mice with CTC 16 cells. |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.